Newron Pharmaceuticals S.p.A. (0QOI.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 03:36PM GMT
| Previous close | 3.1600 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 425,926 |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8500 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
MILAN, January 03, 2023--Newron Pharmaceuticals announces striking six-month interim results for evenamide as an add-on therapy for Treatment Resistant Schizophrenia (TRS).
- Business Wire
Newron provides H1 2022 results and updates on R&D and business activities
MILAN, September 15, 2022--Newron Pharmaceuticals today announces its half-year 2022 financial results and operational highlights and updates its R&D and business activities.
- Business Wire
Newron Extends Senior Management Team and Strengthens Commitment to ESG
MILAN, July 01, 2022--Newron extends Senior Management team and strengthens its commitment to ESG by appointing Filippo Moriggi as Vice President of Operations.
© 2023 Yahoo. All rights reserved.
